Generalized Pustular Psoriasis (GPP) Control is Limited on Traditional Small-molecule Therapy as Measured by the GPP Physician Global Assessment (GPPGA) and Dermatology Life Quality Index (DLQI): Baseline Data from the EFFISAYIL® 2 Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s540, 2025. DOI: 10.25251/skin.10.supp.540. Disponível em: https://skin.dermsquared.com/skin/article/view/3333. Acesso em: 22 jul. 2025.